Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Drop in to find out what we do! Warneford Hospital Wednesday May 22nd 9.30am – 4.00pm

OPEN DAY - Wednesday 22nd May at the Clinical Research Facility

National Institute of Health Research Oxford Cognitive Health Clinical Research Facility

Programme

9.30 - 9.45 Welcome & introduction

Stuart Bell, CEO

9.45 - 10.05 Overview of the University Dept of Psychiatry & Clinical Research Facility

Prof. John Geddes, Director of Research and Development.

10.05 - 10.25 What is Research and Development?

Emma Stratful, Head of Research and Development

10.25 - 10.45 ReDKITE: Resistant Depression Ketamine Infusion Trial Evaluation

Dr. Rupert McShane, Consultant Psychiatrist, Old Age Psychiatry

10.45 - 11.05 IPS-Lite: Refining Individual Placement & Support for UK Practice

Cate Anderson, Research Assistant

11.05 - 11.25 DeNDRoN: Dementia Neurodegenerative Diseases Research Network

Claire Merritt, Lead Research Nurse Manager

11.25 - 11.45 OCTET: Oxford Community Treatment Order Trial

Dr Andrew Molodynski, Consultant Psychiatrist, Adult Mental Health

11:45 – 1.00

Break

1.00 - 1.15 Overview of the University Dept of Psychiatry & Clinical Research Facility

Emma Stratful, Head of Research and Development

1.15 - 1.30 What is Research and Development?

Emma Stratful, Head of Research and Development

1.30 - 1.50 CEQUEL: Comparative Evaluation of QUEtiapine-Lamotrigine

Alex Gardiner, Operations Manager & Senior Clinical Trials Manager

1.50 - 2.10 WIT: Worry Intervention Trial

Dr. Elisa Myers, Research Clinical Psychologist

2.10 - 2.30 OCTUMI-4: Evaluation of Mirtazapine & Folic Acid for Schizophrenia

Dr. Jennifer Rendell, OCHNCTU Head of Clinical Trials, Clinical Trials Unit

2.30 - 2.50 Giving away my brain

Dianna Moylan, Research Participant

2.50 - 3.10 Overview of commercial studies

Dr. Elisa Favaron, Clinical Trials Specialist Doctor

3.10 - 3.30 Using psychology to help understand how antidepressant drugs work.

Dr. Cath Harmer, Professor of Cognitive Neuroscience, University Department of Psychiatry

3.30 - 3.50 MIAMI-UK: Melatonin in Acute mania Investigation

Dr. Digby Quested, Consultant Psychiatrist, Adult Mental Health

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.